Cargando…
Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis
Insulin induced gene-2 (Insig-2) is an ER-resident protein that inhibits the activation of sterol regulatory element-binding proteins (SREBPs). However, cellular factors that regulate Insig-2 expression have not yet been identified. Here we reported that cyclic AMP-responsive element-binding protein...
Autores principales: | Wang, Hai, Zhao, Miaoyun, Sud, Neetu, Christian, Patricia, Shen, Jing, Song, Yongyan, Pashaj, Anjeza, Zhang, Kezhong, Carr, Timothy, Su, Qiaozhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007496/ https://www.ncbi.nlm.nih.gov/pubmed/27582413 http://dx.doi.org/10.1038/srep32246 |
Ejemplares similares
-
Role of cAMP in Double Switch of Glucagon Secretion
por: Zmazek, Jan, et al.
Publicado: (2021) -
A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With Hypertriglyceridemia
por: Katsuyama, Hisayuki, et al.
Publicado: (2023) -
Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP/PKA/CREB pathway
por: Feng, Xu, et al.
Publicado: (2022) -
Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling
por: Chen, Yan, et al.
Publicado: (2022) -
Olfactory receptor 10J5 responding to α-cedrene regulates hepatic steatosis via the cAMP–PKA pathway
por: Tong, Tao, et al.
Publicado: (2017)